PRESS RELEASE: Santhera Publishes Agenda for Annual Shareholders' Meeting

Santhera Pharmaceuticals Holding AG / Santhera Publishes Agenda for Annual Shareholders' Meeting . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.

Liestal, Switzerland, April 18, 2013 - Santhera Pharmaceuticals (SIX: SANN) announced today the agenda for the Annual Shareholder's Meeting at the Company's premises in Liestal on May 13, 2013.

The agenda items are:

1. Approval of the Annual Report, the Annual Financial Statements, the Consolidated Financial Statements for 2012; Acknowledgment of the Reports of the Auditors

2. Appropriation of the Results

3. Set-off of Capital Contribution Reserves and of Free Reserves with Loss Carry Forwards

4. Discharge of the Members of the Board of Directors and of the Executive Management from Liability for the Financial Year 2012

5. Elections of Members of the Board of Directors

6. Re-election of Auditors

7. Continuation of Business Operations or Liquidation/Opting-out/Other Financial and Strategic Measures

The full invitation including detailed information on the agenda, motions and explanations for shareholders is available on the Company's website www.santhera.com under Investors/Shareholders' Meeting.

* * *

For further information, contact

Thomas Meier, Chief Executive Officer

Phone: +41 61 906 89 64

thomas.meier@santhera.com

Disclaimer / Forward-looking statements

This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain forward-looking statements concerning the Company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the Company to be materially different from those expressed or implied by such statements. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. The Company disclaims any obligation to update these forward-looking statements.

News release ASM: http://hugin.info/137261/R/1694245/557136.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Santhera Pharmaceuticals Holding AG via Thomson Reuters ONE

HUG#1694245

--- End of Message ---

Santhera Pharmaceuticals Holding AG

Hammerstrasse 49 Liestal Switzerland

ISIN: CH0027148649;

http://www.santhera.com (END) Dow Jones Newswires

   April 18, 2013 11:36 ET (15:36 GMT)- - 11 36 AM EDT 04-18-13